New era in CNS: Rising from the ashes
30 November 2023
New era in CNS: Rising from the ashes
Super Session 5
Diseases in the central nervous system are devastating for patients and their families and costly for society. Pharma and biotech companies from the Nordics have been actively involved in the recent developments of treatment of Alzheimer’s diseases and other neurological disorders. This session highlights the recent successes in the field of CNS and explores the key factors to advance treatments of CNS diseases.
Moderator(s): Dr. Marc-Olivier Bévierre - Life Science Practice Leader, Vintura
Speaker(s):